2013 American Transplant Congress
Is the Obesity Epidemic in the United States Driving the Lack of Growth of Live Kidney Donation?
Division of Kidney/Pancreas Transplantation, Vanderbilt University Medical Center, Nashville, TN
Introduction: The prevalence of obesity in the United States has increased significantly over the last twenty years and nearly one-third of adults are obese. The…2013 American Transplant Congress
Donor Brain Death Results in Differentially Modulated Immune Activation in Solid Organs
Donor brain death (BD) and its pathophysiological changes have been shown to influence graft quality, therefore accelerating the immune response post transplantation. However, detailed information…2013 American Transplant Congress
Predictors of Clostridium Difficile Infection in Liver Transplant Recipients: A 10 Year Single-Center Cohort Study
Transplant Institute, Henry Ford Hospital, Detroit, MI
Background: Clostridium difficile infection (CDI) is a common cause of morbidity and is associated with increased in-hospital mortality among solid organ transplant recipients. The incidence…2013 American Transplant Congress
Prolonged Cold Ischemia Impairs Outcome in Recipients of Donation after Cardiac Death (DCD) Kidney Transplants Despite Machine Perfusion
Miami Transplant Institute, University of Miami Miller School of Medicine, Miami
Introduction: The impact of prolonged cold ischemia time (CIT) on kidney grafts donated after circulatory death (DCD) remains unclear when grafts were preserved by hypothermic…2013 American Transplant Congress
Associations between Clinical, Biochemical Indicators and Anthropometric Measurements with Arterial Stiffness in Renal Transplantation Patients
Purpose: Arterial stiffness is an independent predictor for cardiovascular mortality. In end stage renal disease cardiovascular risk factors such as age, hypertension and diabetes mellitus…2013 American Transplant Congress
Impact of Prospective Monitoring for Donor Specific Antibodies on Renal Transplant Outcomes with Alemtuzumab Induction
MultiOrgan Transplant Program, William Beaumont Hospital, Royal Oak, MI
Alemtuzumab (AL) induction has been associated with an excess of antibody-mediated rejection (AMR). We initiated a steroid-free AL protocol in August 2009 with prospective monitoring…2013 American Transplant Congress
Multicenter Banff Fibrosis Trial: Comparing Visual Assessment of Interstitial Fibrosis in Kidney Biopsies to Computer-Based Image Analysis and Organ Function, The
Interstitial fibrosis (IF) in renal biopsies is a valuable correlate for organ function, provides prognostic information and is a potential end point in trials.From 15…2013 American Transplant Congress
D-MELD, a Powerful Instrument To Optimize Donor-2-Recipient Match. Differences between US and Italy
Previous studies demonstrated in US and Italy that D-MELD can be an instrument to optimize donor-2-recipient match (D2Rm) in Liver Transplantation.To characterize prognostic power, peculiarities…2013 American Transplant Congress
ATP-Competitive mTORC1 and 2 Inhibitors Are a Novel Class of Immunosuppressants That Suppress Allograft Rejection
Surgery, Starzl Transplant Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA
Introduction: The mammalian Target of Rapamycin (mTOR) is the active catalytic subunit of two mTOR-containing complexes – mTOR complex (mTORC) 1 and mTORC2. mTORC1 is…2013 American Transplant Congress
MicroRNA Profiling in Ischemia Reperfusion Injury Performed by Next Generation Sequencing in Human Renal Transplantation
Objectives: In a variety of (patho-) physiological situations microRNAs, small noncoding RNA fragments of 20-24 bp of length, display import post-transcriptional gene regulators. Current pathology…
- « Previous Page
- 1
- …
- 98
- 99
- 100
- 101
- 102
- …
- 178
- Next Page »